Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.

Pectasides, D

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial. [electronic resource] - European journal of cancer (Oxford, England : 1990) Jan 2000 - 74-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

0959-8049

10.1016/s0959-8049(99)00187-2 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Transitional Cell--drug therapy
Cisplatin--administration & dosage
Docetaxel
Epirubicin--administration & dosage
Female
Humans
Male
Middle Aged
Paclitaxel--administration & dosage
Survival Analysis
Taxoids
Urinary Bladder Neoplasms--drug therapy